Missing/wrong data?
Log in to edit
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.
scientific article published on 16 March 2015
Author/s
author: Antonio C. Wolff, Katherine E Varley, Anna Maria V. Storniolo, William E Grizzle, Hope Rugo, Minetta C Liu, Nancy U Lin
Work details
Publication date
March 16, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.